Resources
About Us
Electrosurgery Market by Product (Monopolar, Bipolar Instrument, Generator, Smoke Evacuation System, Electrode) Surgery (Obstetrics, Cardiovascular, General, Orthopedic, Oncology, Neurosurgery, Cosmetic) End User (Hospital, ASC) – Global Forecast to 2031
Report ID: MRHC - 104712 Pages: 226 Feb-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours Download Free Sample ReportElectrosurgery is a technique used in surgeries to control bleeding and quickly dissect tissues. The electromagnetic current generates heat due to the electrical resistance of the soft tissues. Electrosurgery employs high-frequency electrical current to cut, coagulate, desiccate, and fulgurate tissue. This can be achieved using either monopolar or bipolar instruments. The outcomes of electrosurgery vary depending on factors like power, waveform, and surgical technique, resulting in different effects on the target tissue. Electrosurgical procedures find application in a wide range of surgeries, including obstetrics/gynecology, cardiovascular surgery, general surgery, and cosmetic surgery.
The growth of this market is driven by various factors, including the increasing number of surgical procedures, the growing preference for minimally invasive techniques, the increasing adoption of computer-assisted surgeries, the emergence of medical tourism, particularly in developing nations, the rising incidence of skin, throat, lip, and cervix cancer, and the prevalence of chronic diseases, which is on the rise due to the expanding geriatric population. Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market. Additionally, the increasing concerns regarding the release of toxic fumes during electrosurgical procedures pose a significant challenge to the market’s growth.
The prevalence of chronic diseases, which is on the rise due to the expanding geriatric population, is driving the growth of the electrosurgery market. As per the United Nations data, the percentage of the population aged 65 years or over is increasing globally. In 2022, about 9.7% of the world population was aged 65 years or over, which is expected to increase to 11.7% in 2030 and to 16.4% in 2050. The growing geriatric population is contributing to a rise in chronic disease cases, consequently leading to increased hospital admissions. Older adults, with their lower immunity and decreased adaptability to painful surgical procedures, tend to prefer minimally invasive techniques. This preference is driving the global adoption of electrosurgeries.
The burden of chronic diseases leads to a surge in the number of hospital admissions, leading to the growing demand for electrosurgery devices. For instance, in 2020, the International Agency for Research on Cancer (IARC) projected that globally, 1 in 5 individuals would develop cancer during their lifetime, with 1 in 8 men and 1 in 11 women succumbing to the disease. According to WHO estimates, the global prevalence of cancer is anticipated to rise from 19.2 million new cases in 2020 to 24.5 million new cases by 2030. Concurrently, global cancer-related fatalities are expected to climb from 9.9 million deaths in 2020 to 12.9 million deaths in 2030.
As the burden of diseases continues to grow, certain developing countries are focusing on expanding healthcare facilities and improving the quality of services to alleviate the treatment load. These expansions are expected to drive the growth of the electrosurgery market.
Click here to: Get Free Sample Pages of this Report
Computer-assisted surgeries involve the use of computers for surgical planning. Computers also guide surgeons through surgical interventions in computer-assisted surgeries. Robot-assisted surgeries are part of computer-assisted surgeries. Robot-assisted Surgery (RAS) is being increasingly adopted in general surgical procedures due to features such as operator ergonomics, three-dimensional visualization, improved precision of movement, and wrist dexterity. However, the lack of standardized training and evaluation platforms for robotic proficiency is hindering the widespread adoption of robotic systems. The most widely used RAS system for laparoscopy is the Da Vinci system from Intuitive Surgical (U.S.).
Additionally, Artificial Intelligence (AI) can be integrated into robot-assisted surgical systems to gather data during surgeries for future use. Surgical robots can search through millions of data sets to find crucial insights and cutting-edge procedures using Machine Learning (ML) techniques. For instance, Asensus Surgical (U.S.) has developed the Senhance Surgical System, a robotic surgical system for general laparoscopic surgical procedures. The system assists medical professionals in grasping, cutting, and blunt and sharp dissection in laparoscopic surgeries. In September 2021, the U.S. FDA approved the extended capabilities of this system.
Furthermore, in September 2023, the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) (U.S.) and US Medical Innovations, LLC (USMI) (U.S.) developed the Canady Robotic AI Surgical System. The robotic system generates Cold Atmospheric Plasma (CAP) and a three-dimensional non-contact bioelectric pulsed electromagnetic field. CAP precisely targets and eliminates microscopic tumor cells during surgery.
Based on product, the electrosurgery market is segmented into electrosurgery generators, electrosurgery instruments, accessories, and smoke evacuation systems. In 2024, the electrosurgery generators segment is expected to account for the largest share of the market. The main factors contributing to the large market share of this segment are the high price of generators, technological advancements in electrosurgery generators, and the wide availability of advanced generators.
Based on surgery type, the electrosurgery market is segmented into general surgery, obstetrics/gynecological surgery, orthopedic surgery, cardiovascular surgery, oncology surgery, neurosurgery, cosmetic surgery, urological surgery, and other surgeries. In 2024, the general surgery segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing number of people undergoing general surgeries, driven by the increasing geriatric population, the preference for minimally invasive procedures, and the ongoing advances in surgical devices. For instance, in September 2022, Olympus Corporation (Japan) launched the THUNDERBEAT Open Fine Jaw Type X surgical devices. These devices offer simultaneous delivery of ultrasonic and bipolar energy for tissue management during laparoscopic and open surgeries. By eliminating the need for multiple instruments, they enhance efficiency and reduce operation time.
Based on end user, the electrosurgery market is segmented into hospitals & clinics and ambulatory surgical centers. In 2024, the hospitals & clinics segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to various factors, including the high volume of patient visits, the increasing number of hospitals, the availability of advanced electrosurgery equipment at these facilities, the growing burden of diseases requiring surgical interventions, and the enhanced accessibility to medical practices due to rising healthcare spending. The surge in hospital admissions is primarily driven by the escalating burden of chronic diseases that necessitate surgical interventions. For instance, in January 2022, Mass General Brigham (U.S.), a healthcare system renowned for its medical research, teaching, and patient care, announced a significant expansion plan. This plan includes the construction of a new 482-bed tower at Massachusetts General Hospital, a 78-bed addition to Brigham and Women’s Faulkner Hospital, and the introduction of three comprehensive ambulatory care centers offering physician services, surgery, and diagnostic imaging. Consequently, such expansion efforts are anticipated to drive an increased demand for electrosurgery devices in hospitals.
Asia-Pacific is slated to register the highest CAGR in the electrosurgery market during the forecast period. The growth of this regional market is driven by several factors, including increasing healthcare expenditure, a rising geriatric population, a rapid surge in the prevalence of chronic diseases, growth in per capita income, government initiatives aimed at enhancing healthcare infrastructure, and the proliferation of private hospitals. According to the International Monetary Fund, the region reported an estimated growth of 4.6% in 2023, marking an increase from 3.9% in 2022. The rapid economic development across Asia-Pacific has significantly improved access to healthcare, subsequently driving the market’s growth.
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players over the past three years. The key players profiled in the global electrosurgery market are Medtronic plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), CONMED Corporation (U.S.), Olympus Corporation (Japan), STERIS plc (Ireland), Boston Scientific Corporation (U.S.), B. Braun SE (Germany), BOWA-electronic GmbH & Co. KG (Germany), Erbe Elektromedizin GmbH (Germany), Kirwan Surgical Products, LLC (U.S.), Symmetry Surgical Inc. (U.S.), Surgical Holdings (U.K.), KLS Martin Group (U.S.), I.C. Medical Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Smith and Nephew plc (U.K.).
Particular |
Details |
Page No |
226 |
Format |
|
Forecast Period |
2024-2031 |
Base Year |
2024 |
CAGR |
4.8% |
Market Size (Value) |
$8.99 billion |
Segments Covered |
By Product
By Surgery Type
By End User
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
Key Companies |
Medtronic plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), CONMED Corporation (U.S.), Olympus Corporation (Japan), STERIS plc (Ireland), Boston Scientific Corporation (U.S.), B. Braun SE (Germany), BOWA-electronic GmbH & Co. KG (Germany), Erbe Elektromedizin GmbH (Germany), Kirwan Surgical Products, LLC (U.S.), Symmetry Surgical Inc. (U.S.), Surgical Holdings (U.K.), KLS Martin Group (U.S.), I.C. Medical Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Smith and Nephew plc (U.K.) |
This study offers a detailed assessment of the electrosurgery market, including the market size & forecasts for various segmentations like product, surgery type, and end user. This report also involves the value analysis of various segments of electrosurgery at the regional and country levels.
The global electrosurgery market is projected to reach $8.99 billion by 2031, at a CAGR of 4.8% during the forecast period.
Based on product, the electrosurgery market is segmented into electrosurgery generators, electrosurgery instruments, accessories, and smoke evacuation systems. In 2024, the electrosurgery generators segment is expected to account for the largest share of the market.
Based on surgery type, in 2024, the general surgery segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing number of people undergoing general surgeries, driven by the increasing geriatric population, the preference for minimally invasive procedures, and the ongoing expansion of healthcare facilities.
The growth of this market is driven by various factors, including the increasing number of surgical procedures, the growing preference for minimally invasive techniques, the increasing adoption of computer-assisted surgeries, the emergence of medical tourism, particularly in developing nations, the rising incidence of skin, throat, lip, and cervix cancer, and the prevalence of chronic diseases, which is on the rise due to the expanding geriatric population.
Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
The key players operating in the global electrosurgery market are Medtronic plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), CONMED Corporation (U.S.), Olympus Corporation (Japan), STERIS plc (Ireland), Boston Scientific Corporation (U.S.), B. Braun SE (Germany), BOWA-electronic GmbH & Co. KG (Germany), Erbe Elektromedizin GmbH (Germany), Kirwan Surgical Products, LLC (U.S.), Symmetry Surgical Inc. (U.S.), Surgical Holdings (U.K.), KLS Martin Group (U.S.), I.C. Medical Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Smith and Nephew plc (U.K.).
Emerging economies such as China and India are expected to offer significant market growth opportunities due to rising healthcare expenditures, growth in the geriatric population, and government initiatives aimed at improving healthcare infrastructure.
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates